These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2191783)

  • 1. Hypothesis: warfarin administered simultaneously with heparin infusion will prevent heparin-discontinuance associated coronary thrombosis.
    Craddock LD; Miller B; Krumbach B; Marmont P; Shander D
    Cathet Cardiovasc Diagn; 1990 Jun; 20(2):73-6. PubMed ID: 2191783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive intracoronary infusion of antithrombin III during percutaneous transluminal coronary angioplasty. Results of a prospective, randomized trial.
    Schächinger V; Allert M; Kasper W; Just H; Vach W; Zeiher AM
    Circulation; 1994 Nov; 90(5):2258-66. PubMed ID: 7955182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.
    Granger CB; Miller JM; Bovill EG; Gruber A; Tracy RP; Krucoff MW; Green C; Berrios E; Harrington RA; Ohman EM
    Circulation; 1995 Apr; 91(7):1929-35. PubMed ID: 7895349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The heparin-induced thrombosis-thrombocytopenia syndrome].
    Erni J; Frey HR; Locher G
    Dtsch Med Wochenschr; 1987 May; 112(20):801-5. PubMed ID: 3569071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin III supplementation for patients undergoing PTCA for unstable angina pectoris. A controlled randomized double-blind pilot study.
    Grip L; Blombäck M; Egberg N; Olsson A; Svane B; Velander M
    Eur Heart J; 1997 Mar; 18(3):443-9. PubMed ID: 9076381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of venous thrombosis after total knee arthroplasty. Comparison of antithrombin III and low-dose heparin with dextran.
    Francis CW; Pellegrini VD; Stulberg BN; Miller ML; Totterman S; Marder VJ
    J Bone Joint Surg Am; 1990 Aug; 72(7):976-82. PubMed ID: 1696577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observations during the treatment of antithrombin-III deficient women with heparin and antithrombin concentrate during pregnancy, parturition, and abortion.
    Brandt P
    Thromb Res; 1981 Apr 1-15; 22(1-2):15-24. PubMed ID: 7292437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary angiography and interventions.
    Joost A; Kurowski V; Radke PW
    Curr Pharm Des; 2008; 14(12):1176-85. PubMed ID: 18473864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative efficacy of antithrombin compared with antiplatelet agents in accelerating coronary thrombolysis and preventing early reocclusion.
    Haskel EJ; Prager NA; Sobel BE; Abendschein DR
    Circulation; 1991 Mar; 83(3):1048-56. PubMed ID: 1900222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of arterial reocclusion after thrombolysis with activated protein C. Comparison with heparin in a canine model of coronary artery thrombosis.
    Sakamoto T; Ogawa H; Yasue H; Oda Y; Kitajima S; Tsumoto K; Mizokami H
    Circulation; 1994 Jul; 90(1):427-32. PubMed ID: 8026029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of venous thrombosis in antithrombin III deficient patients with concentrates of antithrombin III.
    Winter JH; Fenech A; Mackie M; Bennett B; Douglas AS
    Clin Lab Haematol; 1982; 4(2):101-8. PubMed ID: 7116792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antithrombin therapy in acute coronary syndromes].
    Maseri A; Andreotti F; Biasucci LM; Rebuzzi AG
    Cardiologia; 1994 Dec; 39(12 Suppl 1):7-13. PubMed ID: 7634317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rethrombosis--warfarin or low-dose heparin?
    Wessler S; Gitel SN
    N Engl J Med; 1979 Oct; 301(16):889-91. PubMed ID: 384252
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators.
    Circulation; 1994 Oct; 90(4):1631-7. PubMed ID: 7923645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in plasma antithrombin (heparin cofactor activity) during intravenous heparin therapy: observations in 198 patients with deep venous thrombosis.
    Holm HA; Kalvenes S; Abildgaard U
    Scand J Haematol; 1985 Nov; 35(5):564-9. PubMed ID: 4089534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of recurrent venous thrombosis: warfarin versus heparin.
    Miller WM; Medbery CA
    N Engl J Med; 1980 Mar; 302(13):752. PubMed ID: 7354791
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thrombin-antithrombin III complexes as a measure of effective heparin treatment?].
    Meyer D; Tsakiris DA; Marbet GA
    Schweiz Med Wochenschr; 1989 Sep; 119(39):1352-4. PubMed ID: 2678451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin deficiency in special clinical syndromes--Part II: cardiovascular surgery.
    Levy JH
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):49-55. PubMed ID: 8821210
    [No Abstract]   [Full Text] [Related]  

  • 20. Prophylactic and therapeutic use of anticoagulants in inherited antithrombin III deficiency.
    Zucker ML; Gomperts ED; Marcus RG
    S Afr Med J; 1976 Oct; 50(43):1743-8. PubMed ID: 63150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.